Can I read March 2021 EyeNet Supplement on EtoBox?

March 2021 EyeNet Supplement by Fede Peralta is a document available to read on EtoBox.

What is March 2021 EyeNet Supplement about?

EYLEA® (aflibercept) Injection is FDA-approved for treating macular edema following retinal vein occlusion (MEfRVO) and has shown significant efficacy in clinical trials. The drug targets vascular endothelial growth factor (VEGF) and placental growth factor (PlGF), which are implicated in the pathogenesis of MEfRVO. Studies indicate that early treatment with EYLEA can lead to improved visual acuity and better patient outcomes compared to control treatments.

Author

Fede Peralta

Language

EN